Search Results - "MIYAMOTO, Fumio"

Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes by Sugiyama, Seigo, Jinnouchi, Hideaki, Kurinami, Noboru, Hieshima, Kunio, Yoshida, Akira, Jinnouchi, Katsunori, Nishimura, Hiroyuki, Suzuki, Tomoko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Tomio

“…Aim: Sodium-glucose co-transporter 2 inhibitor (SGLT2i) therapy has been demonstrated to improve glycemic control and reduce body weight and fat mass in type 2…”
Get full text

The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus by Sugiyama, Seigo, Jinnouchi, Hideaki, Kurinami, Noboru, Hieshima, Kunio, Yoshida, Akira, Jinnouchi, Katsunori, Nishimura, Hiroyuki, Suzuki, Tomoko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Tomio

“…Objective Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce cardiovascular events and decrease the body fat mass in patients with type 2 diabetes…”
Get full text

Reduced Number of Remaining or Healthy Teeth in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study Assessed by Dentists or Dental Hygienists in Japan by Kurinami, Noboru, Ashida, Kenji, Sugiyama, Seigo, Morito, Yoko, Hasuzawa, Nao, Yoshida, Akira, Morita, Ayami, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki, Nomura, Masatoshi

“…Objective This study assessed the relationships between oral health (number of remaining and healthy teeth and periodontal disease) and type 2 diabetes…”
Get full text

Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels by Hieshima, Kunio, Sugiyama, Seigo, Yoshida, Akira, Kurinami, Noboru, Suzuki, Tomoko, Ijima, Hiroko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki

“…Aims/Introduction The renal threshold for glucose (RTg) corresponds to a blood glucose level of ~180 mg/dL; however, in hospitals, patients are often…”
Get full text

Calculated estimation of the metabolic clearance rate of insulin measured by glucose clamp examination in out-patient clinical practice by Kurinami, Noboru, Sugiyama, Seigo, Yoshida, Akira, Hieshima, Kunio, Suzuki, Tomoko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Hideaki

“…Purpose A subpopulation of Japanese patients with type 2 diabetes mellitus (T2DM) who have elevated insulin clearance (IC) exists. We tested our hypothesis…”
Get full text

Severe periodontal disease in Japanese patients with high HbA1c levels: a cross-sectional study by Kurinami, Noboru, Ashida, Kenji, Sugiyama, Seigo, Morito, Yoko, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Hideaki, Nomura, Masatoshi

“…Objective This study aimed to investigate the relationship between plasma glucose profiles and periodontal disease (PD) severity in men and women Methods We…”
Get full text

Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus by Jinnouchi, Tomio, Matsui, Kunihiko, Miyamoto, Fumio, Suzuki, Tomoko, Kurinami, Noboru, Hieshima, Kunio, Yoshida, Akira, Sugiyama, Seigo, Jinnouchi, Hideaki, Kajiwara, Keizo

“…Aims. Glucagon-like peptide-1 (GLP-1) analog promotes insulin secretion by acting on pancreatic β-cells. This antihyperglycemic treatment for type 2 diabetes…”
Get full text

Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus by Kurinami, Noboru, Sugiyama, Seigo, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouch, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki

“…We examined dapagliflozin-induced changes in liver fat accumulation. We prospectively recruited Japanese patients with inadequately controlled type 2 diabetes…”
Get full text

High frequency of defecation under metformin use may be a potential glucose-lowering factor independent of the dose-dependent effect of metformin in patients with type 2 diabetes mellitus by Hieshima, Kunio, Sugiyama, Seigo, Yoshida, Akira, Kurinami, Noboru, Suzuki, Tomoko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki

“…Objective Our previous study indicated that the efficacy of metformin in lowering glycated hemoglobin (HbA1c) levels may be influenced by the pretreatment…”
Get full text

Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naïve type 2 diabetes mellitus by Kurinami, Noboru, Sugiyama, Seigo, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Tomio, Jinnouchi, Hideaki

“…Highlights • Body composition assessed by InBody770 is significantly related to insulin resistance, particularly Muscle / Fat ratio. • The Muscle / Fat ratio…”
Get full text

Detection of wheat as an allergenic substance in food by a nested PCR method by Hashimoto, H.(Chiba-ken. Inst. of Public Health (Japan)), Makabe, Y, Hasegawa, Y, Sajiki, J, Miyamoto, F

“…A nested PCR method was developed for the detection of DNAs extracted from allergenic substances (here, wheat) in food. Because of DNA fragmentation, detection…”
Get full text

Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus by Kurinami, Noboru, Sugiyama, Seigo, Morita, Ayami, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouch, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki

“…Obesity and ectopic fat accumulation are important conditions of type 2 diabetes mellitus (T2DM). Our aim was to determine whether bioelectrical impedance body…”
Get full text

Body muscle-to-fat ratio gender-specific cut-off values for impaired insulin sensitivity in patients with treatment-naïve type 2 diabetes mellitus by Kurinami, Noboru, Sugiyama, Seigo, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouch, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki

“…Purpose We previously reported that the body muscle-to-fat ratio (BMFR), measured using bioelectrical impedance, significantly correlated with whole-body…”
Get full text

Clinical usefulness of the body muscle-to-fat ratio for screening obstructive sleep apnea syndrome in patients with inadequately controlled type 2 diabetes mellitus by Kurinami, Noboru, Sugiyama, Seigo, Ijima, Hiroko, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouch, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki

“…To investigate whether body composition measures can be used for screening obstructive sleep apnea syndrome (OSAS) in patients with type 2 diabetes mellitus…”
Get full text

Characteristics of nephropathy in severely obese Japanese patients complicated with type 2 diabetes mellitus: a cross-sectional cohort study by Kurinami, Noboru, Sugiyama, Seigo, Ijima, Hiroko, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Tomio, Nomura, Masatoshi, Jinnouchi, Hideaki

“…Purpose We aimed to investigate the characteristics of kidney disease in severely obese Japanese patients with type 2 diabetes mellitus (T2DM). Methods This…”
Get full text

Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus by Kurinami, Noboru, Sugiyama, Seigo, Nishimura, Hiroyuki, Morita, Ayami, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki

“…Background and objective Obesity is globally recognized as an important clinical problem and sodium-glucose co-transporter 2 (SGLT2) inhibitors are considered…”
Get full text

Improvement of Glycemic Control by Metformin Is Associated With Frequency of Defecation Before Treatment in Patients With Type 2 Diabetes Mellitus by Hieshima, Kunio, Sugiyama, Seigo, Yoshida, Akira, Kurinami, Noboru, Suzuki, Tomoko, Otsuka, Kaori, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki

Get full text

Potential Identification of Type 2 Diabetes with Elevated Insulin Clearance by Sugiyama, Seigo, Jinnouchi, Hideaki, Hieshima, Kunio, Kurinami, Noboru, Jinnouchi, Katsunori, Yoshida, Akira, Suzuki, Tomoko, Kajiwara, Keizo, Miyamoto, Fumio, Jinnouchi, Tomio

“…BACKGROUND: Decreased blood insulin concentrations resulting from reduced pancreatic β-cell insulin secretion and elevated insulin clearance (IC) could be…”
Get more information

Body Muscle-to-Fat Ratio, Rather Than Fat-to-Muscle Ratio, Significantly Correlates With Measured Insulin Resistance in Patients With Type 2 Diabetes Mellitus by Kurinami, Noboru, Sugiyama, Seigo, Yoshida, Akira, Hieshima, Kunio, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouch, Katsunori, Jinnouchi, Tomio, Nomura, Masatoshi, Jinnouchi, Hideaki

“…BACKGROUNDInsulin resistance (IR) assessment is important in treating type 2 diabetes mellitus (T2DM). We thus compared body muscle-to-fat ratio (BMFR) and…”
Get full text

Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center by Sugiyama, Seigo, Jinnouchi, Hideaki, Yoshida, Akira, Hieshima, Kunio, Kurinami, Noboru, Jinnouchi, Katsunori, Tanaka, Motoko, Suzuki, Tomoko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Tomio

“…Large randomized clinical trials of patients with type 2 diabetes mellitus (T2DM) and at high risk for cardiovascular disease revealed that sodium-glucose…”
Get full text